Intellia Therapeutics (NTLA) Q2 2026 Earnings

11MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.02
-0.95
-0.88
-0.81

Details

Expected EPS
-0.910694
Actual EPS
-0.81
Surprise EPS
0.1
Surprise Percent
+11.06%

Description

Intellia Therapeutics (NTLA) has reported earnings of -0.81 per share for Q2 2026.

0 Comments

Share your thoughts